FDA Reporter
Unauthorized
October 14, 2020
WAKIX is the first and only non-scheduled treatment approved for excessive daytime sleepiness or cataplexy in adult patients with narcolepsy
Sign-up for the Weekly Newsletter from FDA Reporter.